MedinCell S.A. (MDCLF)
USD 6.98
(-0.06%)
USD 6.98
(-0.06%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 58.96 Million EUR | 2.17% |
| 2023 | 57.7 Million EUR | 21.51% |
| 2022 | 47.49 Million EUR | 9.57% |
| 2021 | 43.34 Million EUR | 28.1% |
| 2020 | 33.83 Million EUR | 25.16% |
| 2019 | 27.03 Million EUR | -12.78% |
| 2018 | 30.99 Million EUR | 49.71% |
| 2017 | 20.7 Million EUR | 379.06% |
| 2016 | 4.32 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 65.41 Million EUR | 13.36% |
| 2024 Q2 | 63.2 Million EUR | -3.38% |
| 2024 Q3 | 64.06 Million EUR | 1.35% |
| 2024 Q4 | 58.96 Million EUR | -7.96% |
| 2024 FY | 58.96 Million EUR | 2.17% |
| 2023 Q4 | 57.7 Million EUR | 1.13% |
| 2023 Q1 | 47.83 Million EUR | 0.72% |
| 2023 Q2 | 48.46 Million EUR | 1.31% |
| 2023 Q3 | 57.06 Million EUR | 17.75% |
| 2023 FY | 57.7 Million EUR | 21.51% |
| 2022 Q2 | 45.09 Million EUR | 0.98% |
| 2022 FY | 47.49 Million EUR | 9.57% |
| 2022 Q4 | 47.49 Million EUR | 1.24% |
| 2022 Q3 | 46.9 Million EUR | 4.03% |
| 2022 Q1 | 44.65 Million EUR | 3.02% |
| 2021 Q1 | 43.7 Million EUR | 29.15% |
| 2021 FY | 43.34 Million EUR | 28.1% |
| 2021 Q4 | 43.34 Million EUR | 0.91% |
| 2021 Q3 | 42.95 Million EUR | -2.39% |
| 2021 Q2 | 44 Million EUR | 0.7% |
| 2020 FY | 33.83 Million EUR | 25.16% |
| 2020 Q4 | 33.83 Million EUR | 0.96% |
| 2020 Q3 | 33.51 Million EUR | 1.43% |
| 2020 Q2 | 33.04 Million EUR | 0.56% |
| 2020 Q1 | 32.85 Million EUR | 21.54% |
| 2019 FY | 27.03 Million EUR | -12.78% |
| 2019 Q4 | 27.03 Million EUR | 0.21% |
| 2019 Q2 | 43.99 Million EUR | 0.14% |
| 2019 Q3 | 26.97 Million EUR | -38.68% |
| 2019 Q1 | 43.93 Million EUR | 41.74% |
| 2018 Q3 | 30.95 Million EUR | 0.0% |
| 2018 Q4 | 30.99 Million EUR | 0.15% |
| 2018 FY | 30.99 Million EUR | 49.71% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 FY | 20.7 Million EUR | 379.06% |
| 2016 FY | 4.32 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Neon Bloom, Inc. | 630.07 Thousand USD | -9257.745% |
| Adynxx, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -35.939% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -48031.429% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -29.414% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -16657.568% |
| Rebus Holdings, Inc. | 310 Thousand USD | -18919.677% |
| Skye Bioscience, Inc. | 4.61 Million USD | -1177.521% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -98.074% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -229150.748% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -904.26% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -43.099% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -1330.413% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -14572.427% |
| SQZ Biotechnologies Company | 27.47 Million USD | -114.63% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -2434.916% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -6117.737% |
| Mesoblast Limited | 118.7 Million USD | 50.328% |
| Marizyme, Inc. | 18.71 Million USD | -215.005% |
| Genus plc | 233.1 Million USD | 74.706% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -1912.054% |
| Pharming Group N.V. | 171.54 Million USD | 65.629% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -6539.274% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -4288.337% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -7761.467% |
| ContraFect Corporation | 2.88 Million USD | -1946.546% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -43417.828% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -3976.625% |
| IMV Inc. | 28.88 Million USD | -104.131% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -942.017% |
| MultiCell Technologies, Inc. | 202.58 USD | -29104944.921% |
| ONE Bio Corp. | 19.71 Million USD | -199.066% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -2.56% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -3844.537% |
| Q BioMed Inc. | 4.1 Million USD | -1334.581% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -78.125% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -4699.973% |
| Biomind Labs Inc. | 735.54 Thousand USD | -7915.994% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 12.835% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -1848.357% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -353.651% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -16291.26% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -41563.251% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -2510.764% |
| GB Sciences, Inc. | 1.75 Million USD | -3251.376% |
| Alpha Cognition Inc. | 1.22 Million USD | -4731.396% |
| HST Global, Inc. | 98.31 Thousand USD | -59869.08% |
| CSL Limited | 12.18 Billion USD | 99.516% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -23605.774% |
| Halberd Corporation | 150 Thousand USD | -39207.333% |
| Enzolytics Inc. | 996.33 Thousand USD | -5817.771% |
| Agentix Corp. | 50 Thousand USD | -117822.0% |
| Resverlogix Corp. | 6.49 Million USD | -808.35% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -22968.406% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -194.805% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -733.629% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -2076.724% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -576535.697% |
| Genscript Biotech Corporation | 417.73 Million USD | 85.886% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -29289.979% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -2359.04% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -25614.485% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -39563.245% |
| Kadimastem Ltd | 891.22 Thousand USD | -6515.718% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -190.048% |
| BioStem Technologies, Inc. | 4.71 Million USD | -1151.449% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -23467.243% |
| LadRx Corporation | 33.6 Thousand USD | -175347.837% |
| Cell Source, Inc. | 9.25 Million USD | -537.129% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -7696.97% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -7696.97% |
| NovAccess Global Inc. | 2.19 Million USD | -2580.192% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -25717.398% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -27846.913% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -1083.243% |
| Mobile Lads Corp. | 484.28 Thousand USD | -12074.881% |
| CytoDyn Inc. | 30.07 Million USD | -96.04% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -653.981% |
| SYBLEU INC | 477.5 Thousand USD | -12247.853% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -1145.142% |
| International Stem Cell Corporation | 4.17 Million USD | -1311.225% |
| Bioxytran, Inc. | 1.92 Million USD | -2962.909% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -94369.101% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -2603.517% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -609.007% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -586.791% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -3690.537% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -21900.373% |
| Neutra Corp. | 54.15 Thousand USD | -108772.516% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -3121.913% |
| PureTech Health plc | 25.51 Million USD | -131.111% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -4716.186% |
| IXICO plc | 472.02 Thousand USD | -12391.129% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -280.369% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 5.303% |
| CSL Limited | 12.18 Billion USD | 99.516% |
| Cellectis S.A. | 92.77 Million USD | 36.448% |